Microarray analysis revealed that p53R2, ribonucleotide reductase regulatory TP53 inducible subunit M2B, is overexpressed in gemcitabine-resistant CCA cell lines [37]. This evidence concerns the gene RRM2B and cholangiocarcinoma.